HPTN Studies

 

Study Snapshot

Study Timelines

Filter studies by:

A Phase II randomized, observer-blind, placebo-controlled study, to assess efficacy of meningococcal Group B vaccine rMenB+OMV NZ (Bexsero) in preventing gonococcal infection.

Closed to Accrual

HPTN 106 (39002)

A Phase 2 Crossover Study of On Demand PrEP Formulations Comparing Rectal and Oral TFV-Based PrEP Evaluating Extended Safety, Acceptability, and PK/PD

Closed to Accrual

HPTN 104 (39007)

A multisite, open-label, randomized crossover study comparing adherence to a single daily dual prevention pill (DPP) versus FTC/TDF and Combined Oral Contraception separate pill dosing (2PR), given for pre-exposure prophylaxis and pregnancy prevention in women

Pending

A phase 1 dose-escalation clinical trial to evaluate the safety, tolerability, and pharmacokinetics of PGDM1400LS alone and in combination with VRC07-523LS and PGT121.414.LS in healthy, HIV-uninfected adult participants

Closed to Follow Up

Antibody Mediated Prevention

CoVPN 5002 (38749)

SARS-CoV-2 Prevalence Survey

Closed to Follow Up

COVID-19

HPTN 083-02 (38645)

Factors Influencing Adherence to Injectable PrEP and Retention in an Injectable PrEP Research Study

Closed to Follow Up

PrEP

HPTN 096 (38561)

Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy

Enrolling

Integrated Strategy

Antiretroviral analytical treatment interruption (ATI) to assess immunologic and virologic responses in participants who received VRC01 or placebo and became HIV-infected during HVTN 704/HPTN 085

Closed to Follow Up

Other